Prognostic and predictive value of p-Akt, EGFR, and p-mTOR in early breast cancer.
Lazaridis G, Lambaki S, Karayannopoulou G, Eleftheraki AG, Papaspirou I, Bobos M, Efstratiou I, Pentheroudakis G, Zamboglou N, Fountzilas G.
Lazaridis G, et al. Among authors: lambaki s.
Strahlenther Onkol. 2014 Jul;190(7):636-8, 640-5. doi: 10.1007/s00066-014-0620-6.
Strahlenther Onkol. 2014.
PMID: 24658605
Clinical Trial.